Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock price of $387.12. The high star ratings enhance Humana's eligibility for quality-related bonus payments, supporting the positive outlook. Oppenheimer maintains an 'Outperform' rating, expecting Humana's stock to outperform the broader market.
Following Oppenheimer's upgrade of Humana's price target, the stock is trading notably higher on Pluang, priced at USD 453.50 as of Oct 09, 2026 20:41 WIB, marking a 17.15% increase in one day. The market capitalization stands at $46.49 billion, with investors typically holding the stock for 53 days. Humana also offers a dividend yield of 0.91%, highlighting its appeal to income-focused investors.
Humana's stock surged after its main Medicare Advantage plan regained a 4-star rating for 2027 from the Centers for Medicare and Medicaid Services, up from 3.5 stars in 2026. This upgrade means 95% of Humana's Medicare Advantage members will be in pl...
The Centers for Medicare & Medicaid Services (CMS) announced an 18% drop in Medicare Advantage contracts rated four stars or higher for 2027, due to changes in rating criteria including new medication-safety measures and increased weight on physical ...
Humana's shares rose nearly 15% after the company improved its Medicare Advantage quality ratings for 2027, with about 95% of members enrolled in plans rated at least four stars. The company now has 18 contracts rated four stars or higher, including ...
Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detect...
Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...
